Clive Roper
BSc, PhD, CBiol, CSci, ERT, FRSB
Director, Roper Toxicology Consulting Limited
Experience
April 2021Â - Present
Director, Owner and Founder, Roper Toxicology Consulting Limited
March 2021Â - Present
January 2021Â - Present
August 2010 - February 2020
UK NC3Rs
Charles River Laboratories, Edinburgh, UK
-
People management
-
Multimillion dollar budget
-
Business and department growth
-
BD
-
NAMs development
-
In vitro skin absorption
-
In vitro respiratory toxicology
-
In vitro safety pharmacology
-
Genetic toxicology
-
In vitro metabolism
-
Speaker
-
Leader
-
3Rs working group (corporate)
-
Technology evaluation (corporate)
March 2020Â - February 2021
Charles River Laboratories, Edinburgh, UK
-
People management
-
Multimillion dollar budget
-
Business and department growth
-
BD
-
NAMs development
-
In vitro skin absorption
-
In vitro respiratory toxicology
-
In vitro safety pharmacology
-
Advanced in vitro tissue models
-
Speaker
-
Leader
-
3Rs working group (corporate)
-
Technology evaluation (corporate)
June 1996 - August 2010
Charles River Laboratories Edinburgh Limited
Scientific Manager (January 2003 - August 2010)
Study Director (July 1997 - December 2002)
Research Officer (June 1996 - June 1997).
-
Founding member and board member of the 3Rs Collaborative
-
Vice President and board member of ESTIV
-
Board chairperson of PeptiMatrix
-
Member of the UK NC3Rs board
-
European Registered Toxicologist (ERT)
-
Fellow of the Royal Society of Biology (FRSB)
-
Active member of leading societies like ASCCT, SOT, ACT, and ACTC
Professional Leadership
-
Founding member and board member of the 3Rs Collaborative
-
Vice President and board member of ESTIV
-
Board chairperson of PeptiMatrix
-
Member of the UK NC3Rs board
-
European Registered Toxicologist (ERT)
-
Fellow of the Royal Society of Biology (FRSB)
-
Active member of leading societies like ASCCT, SOT, ACT, and ACTC
Education
October 1990Â - April 1994
DOCTOR OF PHILOSOPHY
Department of Environmental and Occupational Medicine, Newcastle University & Unilever Research, Sharnbrook, Bedfordshire, UK.
In vitro skin absorption and toxicology
PhD thesis: In vitro approaches to the prediction of percutaneous absorption and metabolism: a study of ethoxylates.
September 1987Â - June 1990
BACHELOR OF SCIENCE
Department of Agricultural Biochemistry and Nutrition, Newcastle University.
Agricultural Biochemistry and Nutrition, BSc (Hons) 2:1.
Achievements
• Developing a NAM for respiratory toxicology, representing this to the US EPA Special Advisory Panel, receiving a personal invitation to attend the EPA NAM conferences, being acknowledged as an EPA stakeholder for their animal-free 2035 plans and writing the NAM as a case study now accepted for publication by the OECD
• 4 of my peer review papers are quoted in OECD test guidelines (OECD 428 and OECD 492)
Current Memberships
-
Board member at the 3Rs Collaborative (3RsC)
-
Board member at the Nationale Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs)
-
Board member at the European Society of In Vitro Toxicology (ESTIV)
-
Fellow of the Royal Society of Biology (FRSB)
-
Chartered Biologist (CBiol)
-
Chartered Scientist (CSci)
-
Member of the European Registered Toxicologist (ERT)​
-
Member of the Society of Toxicology (SOT)​
-
Member of the Regulatory and MPS Subgroups of the 3RsC ​
-
Member of the American Society for Cellular and Computational Toxicology (ASCCT)
-
Member of the International Microphysiological Systems Society (IMPSS)
-
Member of The Roundtable of Toxicology Consultants (toxconsultants.com)
-
Member of the RESPTox Acute In Vitro Respiratory Group